Navigation Links
InspireMD Reports 2012 Fiscal Year Results
Date:9/12/2012

TEL AVIV, Israel, September 12, 2012 /PRNewswire/ --

InspireMD, Inc. (OTC BB NSPR) (the "Company" or "InspireMD"), a medical device company focusing on the development and commercialization of its proprietary embolic protection stent platform technology for use in patients with Acute Myocardial Infarctions, today announced financial results for the six months ended June 30, 2012.

As previously announced, the Company changed its fiscal year end to June 30. As a result, the six months ended June 30, 2012 represent a transition period, with the next fiscal year covering the period from July 1, 2012 through June 30, 2013

"Several key milestones were achieved during the six months ended June 30, 2012," said Ofir Paz, Co-founder and CEO of InspireMD.  We completed enrollment in the nine-country, 433-patient MASTER trial ahead of schedule, raised $11 million with a convertible debt offering and strengthened senior management.

"Subsequently, on August 20, we received notice that the MASTER trial comparing the MGuard™ embolic prevention stent to commercially-approved bare metal or drug-eluting stents in heart attack patients undergoing primary percutaneous coronary intervention (PCI) demonstrated a positive outcome," he added. "This is a significant milestone for InspireMD.  We are eagerly awaiting presentation of the study's findings at the Transcatheter Cardiovascular Therapeutics (TCT) meeting next month in Miami."

The MASTER (MGuard for Acute ST Elevation Reperfusion) trial is the first company-sponsored randomized clinical study of the MGuard™ embolic protection stent.

In eleven prior single arm studies and a 40-patient physician-sponsored randomized trial, the MGuard™ embolic protection stent showed effectiveness in restoring blood flow and reducing major adverse events following heart attack stenting.

About 3.2 m
'/>"/>

SOURCE InspireMD, Inc
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related biology technology :

1. InspireMD to Present at JMP Securities Healthcare Conference on July 12th in New York
2. InspireMD to Present at JMP Securities Healthcare Conferenceon July 12th in New York
3. InspireMD Appoints Dr. James Barry to Its Board of Directors
4. InspireMD Elects Sol J. Barer, Ph.D. Chairman of the Board of Directors
5. Palatin Technologies, Inc. Reports Fourth Quarter and Fiscal Year End 2012 Results
6. Orthobiologics Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2018: China Market Research Reports
7. AFCell Medical Reports Results from the Retrospective Study of a Novel Allograft Membrane to Prevent Post-Operative Adhesions in the Repair of Peroneal and Posterior Tibial Tendons
8. China Cord Blood Corporation Reports Financial Results for the First Quarter of Fiscal 2013
9. Perrigo Reports Record Fourth Quarter and Fiscal Year Revenue, Earnings and Cash Flow From Operations
10. China Biologic Reports Financial Results for the Second Quarter and First Half of 2012
11. BioSpecifics Technologies Corp. Reports Second Quarter 2012 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/22/2014)... 22, 2014 The Board of Directors of BD ... declared a quarterly dividend of 54.5 cents per common share ... September 9, 2014. The indicated annual dividend rate is $2.18 ... is a leading medical technology company that partners with customers ... and evolving health needs. Our innovative solutions are focused on ...
(Date:7/22/2014)... within a phylum so full of mean little creatures, the ... its cruelty -- at least to crickets. Native to the ... most predatory sort of parasite. It swoops onto the back ... and leaves its wicked brood to invade, kill and consume ... would be possible without the fly,s ability to find a ...
(Date:7/22/2014)... Institute of Standards and Technology (NIST) and California ... design for an atomic clock that is based ... , The microcomb clock, featured on the cover ... Optica ,* is the first demonstration of ... conversion of optical frequencies to lower microwave frequencies. ...
(Date:7/22/2014)... in water with ultrasound and they,ll spin around their ... yet knows exactly. But researchers at the National Institute ... it,s fast. At up to 150,000 revolutions per minute, ... object submerged in liquid ever reported. , The discovery ... that they could be used not only for moving ...
Breaking Biology Technology:Fly-inspired sound detector 2Fly-inspired sound detector 3Fly-inspired sound detector 4'Comb on a chip' powers new NIST/Caltech atomic clock design 2NIST shows ultrasonically propelled nanorods spin dizzyingly fast 2
... the Albert Einstein College of Medicine of Yeshiva University ... can cure hemophilia A (the most common form of ... online February 14 in the Journal of Clinical Investigation. ... is characterized by recurrent, spontaneous bleeding that can cause ...
... at the University of Illinois helped lead a ... strategy for serious Staphylococcus aureus (Staph) infections. The ... version of Science magazine, comes at a time ... for methicillin-resistant S. aureus) are spreading in epidemic ...
... Hospital(R), the premier pediatric research and treatment center, can ... ... More than 60,000 callers,generated $6.1 million dollars during the ... a division of Univision,Communications Inc. The radiothon, benefiting St. Jude ...
Cached Biology Technology:Transplanted cells may hold the key to curing hemophilia A, Einstein scientists report 2New approach may render disease-causing staph harmless 2New approach may render disease-causing staph harmless 3More than $6 Million Raised During Two-Day Event to Support Research and Treatment for Childhood Cancer and Other Catastrophic Diseases 2More than $6 Million Raised During Two-Day Event to Support Research and Treatment for Childhood Cancer and Other Catastrophic Diseases 3
(Date:7/22/2014)... exhibit consists of both still images and video ... scientific research. Forty-four still images were chosen from ... postdocs, staff, and alumni representing more than 25 ... more than 50 submissions. , Zach Donnell, a ... the 2014 organizers, noted that the exhibit highlights ...
(Date:7/22/2014)... Aware, Inc. (NASDAQ: AWRE ), a ... results for its second quarter ended June 30, 2014. ... million, an increase of 53% compared to $4.4 million in ... income in the second quarter of 2014 was $1.4 million ... The increase in revenue and operating income was driven by ...
(Date:7/22/2014)... professor with an expertise in big data and bioinformatics ... more than $600,000 to develop an interactive database of ... associate professor, will lead the project with professor Chris ... Engineering department. Scientists are compiling and studying data related ... involved in fruit fly development are commonly found in ...
Breaking Biology News(10 mins):Art of Science 2014 2Aware, Inc. Reports Second Quarter 2014 Financial Results 2Aware, Inc. Reports Second Quarter 2014 Financial Results 3Aware, Inc. Reports Second Quarter 2014 Financial Results 4Aware, Inc. Reports Second Quarter 2014 Financial Results 5Aware, Inc. Reports Second Quarter 2014 Financial Results 6Aware, Inc. Reports Second Quarter 2014 Financial Results 7UT Arlington big data team wins $600,000 NSF grant to build gene expression database 2
... will host its largest ever annual meeting next week ... diagnostic professionals plus 1,300 representatives from more than 180 ... sessions and 350 poster presentations, the AMP 2013 Annual ... all things molecular. The event, to be held November ...
... membrane-crossing pores, using Lego-like DNA building blocks, has been developed ... University of Cambridge and the University of Southampton. ... synthetic biology and the technique has potential applications in diagnostic ... current issue of the journal Angewandte Chemie . ...
... Mass. (November 4, 2013) Whitehead Institute scientists report ... known as Birt-Hogg-Dub cancer syndrome also prevents activation of ... This is an unexpected finding, as ... their unchecked growth and expansion. In the case of ...
Cached Biology News:The Association for Molecular Pathology announces highlights of Phoenix meeting 2Designer piercings: New membrane pores with DNA nanotechnology 2Designer piercings: New membrane pores with DNA nanotechnology 3Gene responsible for hereditary cancer syndrome found to disrupt critical growth-regulating pathway 2
Denhardt's Solution is a mixture of blocking agents used in membrane-based hybridization protocols. The solution contains 1% Ficoll (type 400) 1% polyvinylpyrrolidone and 1% bovine serum albumin. Ste...
... 97 Cytological Labeling Kit provides a unique ... of cellular targets, including cell-surface receptors and ... Kit contains the patented ELF 97 phosphatase ... precipitate at the site of enzymatic activity ...
... H 10 O 2 S 2 ... Form: White crystalline powder Assay: greater ... By IR Melting Point: greater than ... less than or equal to 1% ...
... consists of an anodized aluminum body in ... Compounds embedded in polymerized matrix. It is ... and Synergy Multi-Detection Readers. This multi-functional test ... reducing the need for tedious wet testing. ...
Biology Products: